TABLE I.
CD No. | 1 (D-11, P-LA1, VR-7D) |
2 (D-Mac, P-LA2, VR-8A) |
3–4 (D-3, VR-4A) |
5 (D-9, P-4D, VR-6B) |
6 (D-6, P-4C, VR-9A) |
7 (D-7, VR-4B) |
Unclassified | Preformed antibodies |
Summary, grade |
Survival, mos. |
Present creatinine clearance, ml/min. |
---|---|---|---|---|---|---|---|---|---|---|---|
10 | + | − | − | − | − | − | Many | No | C | 11 | 15 |
11 | − | − | − | + | − | − | Many | No | C − | Died— 3½ | * |
12 | − | + | − | − | − | − | Many | No | D | Died— 3½ | * |
13 | + | − | − | − | − | − | Many | Yes | D | 5½ | 95 |
14 | + | − | − | − | − | − | Many | No | C | 4½ | 47 |
15 | − | − | + | − | + | − | Many | No | D | 3 | 55 |
The antigenic incompatibilities between donors and recipients are shown, and the probable correspondence of the Terasaki groups to those of Dausset (D), Payne (P), and van Rood (VR) are indicated in parentheses. The unclassified antigens were also considered in deciding upon a summary grade.
These 2 patients received homografts from a common donor. Both died after 3½ months within a 24 hour period. The cause of death in each was multiple pulmonary embolization, a fatal complication not seen in our institutions after renal transplantation since 1964.
CD, cadaveric.